Loading...
Loading...
ADTX| Name | Value |
|---|---|
| Revenues | 44.3K |
| Cost of Revenue | 181.2K |
| Gross Profit | -136.9K |
| Operating Expense | 5,839.1K |
| Operating I/L | -5,976.0K |
| Other Income/Expense | -1,647.9K |
| Interest Income | 0.4K |
| Pretax | -7,623.9K |
| Income Tax Expense | -74.3K |
| Net Income/Loss | -7,549.6K |
Aditxt, Inc. is a biotech company specializing in immune system health technologies. The company's main products include AditxtScore, which provides individuals with insights into their immune profiles, and Apoptotic DNA Immunotherapy, a nucleic acid-based technology for inducing tolerance to tissues. Aditxt, Inc. is also developing ADi products for organ transplantation, skin grafting, autoimmune diseases, and allergies. The company generates revenue through the sale of its immune mapping and reprogramming technologies, as well as through potential future sales of its ADi products for various medical applications.
